Quarterly Schedule of Portfolio Holdings of Registered
|
Management Investment Company
|
Investment Company Act file number: 811-05807
|
Eagle Capital Growth Fund, Inc.
|
(Exact name of registrant as specified in charter)
|
|
205 E. Wisconsin Ave, Suite 120, Milwaukee, WI 53202
|
(Address of principal executive offices) (zip code)
|
Luke E. Sims, President
|
Eagle Capital Growth Fund, Inc.
|
205 E. Wisconsin Ave
|
Suite 120
|
Milwaukee, WI 53202
|
(414) 765-1107
|
(Name and address of agent for service)
|
Registrant's telephone number, including area code:
|
Industry
|
||||||||||||||||
Common Stock (96.0% of total investments)
|
||||||||||||||||
Consumer
|
Shares
|
Cost
|
Market Value
|
% Total Inv.
|
||||||||||||
Alcon Inc.*
|
6,000 | $ | 975,788.20 | $ | 993,060 | |||||||||||
Colgate-Palmolive Co.
|
12,000 | $ | 417,940.00 | $ | 969,120 | |||||||||||
PepsiCo Inc.
|
10,000 | $ | 168,295.88 | $ | 644,100 | |||||||||||
Procter & Gamble Co.
|
18,000 | $ | 1,079,133.50 | $ | 1,108,800 | |||||||||||
$ | 3,715,080 | (15.1 | %) | |||||||||||||
Data Processing
|
||||||||||||||||
Automatic Data Processing, Inc.
|
34,000 | $ | 1,278,025.09 | $ | 1,744,540 | |||||||||||
Paychex Inc.
|
34,000 | $ | 907,966.94 | $ | 1,067,090 | |||||||||||
$ | 2,811,630 | (11.4 | %) | |||||||||||||
Drug/Medical Device
|
||||||||||||||||
Abbott Laboratories Inc.
|
30,000 | $ | 1,522,346.50 | $ | 1,471,500 | |||||||||||
Baxter International
|
8,000 | $ | 402,596.00 | $ | 430,160 | |||||||||||
Johnson & Johnson
|
18,500 | $ | 824,138.70 | $ | 1,096,125 | |||||||||||
Medtronic, Inc.
|
17,000 | $ | 567,183.07 | $ | 668,950 | |||||||||||
Pfizer Inc.
|
38,737 | $ | 522,042.01 | $ | 786,748 | |||||||||||
Stryker Corp.
|
22,000 | $ | 180,012.00 | $ | 1,337,600 | |||||||||||
$ | 5,791,083 | (23.5 | %) | |||||||||||||
Industrial
|
||||||||||||||||
General Electric Co.
|
35,000 | $ | 401,457.70 | $ | 701,750 | |||||||||||
Graco Inc.
|
13,750 | $ | 349,685.50 | $ | 625,488 | |||||||||||
Hillenbrand, Inc.
|
22,000 | $ | 446,355.80 | $ | 473,000 | |||||||||||
Sigma-Aldrich Corp.
|
16,000 | $ | 498,183.75 | $ | 1,018,240 | |||||||||||
Waters Corp.*
|
6,000 | $ | 302,341.38 | $ | 521,400 | |||||||||||
$ | 3,339,878 | (13.6 | %) | |||||||||||||
Mutual Fund Managers
|
||||||||||||||||
Eaton Vance Corp.
|
22,000 | $ | 483,868.80 | $ | 709,280 | |||||||||||
Federated Investors, Inc.
|
40,000 | $ | 909,365.20 | $ | 1,070,000 | |||||||||||
$ | 1,779,280 | (7.2 | %) | |||||||||||||
Insurance
|
||||||||||||||||
The Chubb Corporation
|
16,000 | $ | 819,772.00 | $ | 980,960 | |||||||||||
$ | 980,960 | (4.0 | %) | |||||||||||||
Retail/Distribution
|
||||||||||||||||
Best Buy Co. Inc.
|
31,000 | $ | 1,057,842.90 | $ | 890,320 | |||||||||||
The Home Depot, Inc.
|
28,000 | $ | 758,909.60 | $ | 1,037,680 | |||||||||||
Lowe's Companies Inc.
|
35,000 | $ | 708,771.10 | $ | 925,050 | |||||||||||
Sysco Corp.
|
27,000 | $ | 309,198.72 | $ | 747,900 | |||||||||||
$ | 3,600,950 | (14.6 | %) | |||||||||||||
Closed-End Funds
|
||||||||||||||||
Claymore Dividend & Income Fund
|
83,000 | $ | 1,133,654.00 | $ | 1,380,290 | |||||||||||
Diamond Hill Financial Trends Fund, Inc.
|
23,938 | $ | 243,180.60 | $ | 237,412 | |||||||||||
$ | 1,617,702 | (6.6 | %) | |||||||||||||
Total common stock investments
|
$ | 23,636,563 | ||||||||||||||
Cash and cash equivalents (4.0% of total investments)
|
$ | 972,566 | ||||||||||||||
Total investments
|
$ | 24,614,939 | ||||||||||||||
All other assets less liabilities
|
$ | 33,241 | ||||||||||||||
Total net assets
|
$ | 24,642,370 |
Gross unrealized appreciation
|
$ | 6,592,646 | ||
Gross unrealized depreciation
|
(224,138 | ) | ||
Net unrealized appreciation
|
$ | 6,368,508 | ||
Federal income tax basis
|
$ | 17,268,055 |
|
(a)
|
As of April 1, 2011, an evaluation of the effectiveness of the registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) was performed by management with the participation of the registrant's President and Chief Executive Officer (who is the principal executive officer of the registrant) and the registrant’s Chief Financial Officer (who is the principal financial officer of the registrant). Based on that evaluation, the registrant's President and Chief Executive Officer and Chief Financial Officer concluded that the registrant's disclosure controls and procedures are effectively designed to ensure that information required to be disclosed by the registrant is recorded, processed, summarized and reported within the time periods specified by the Commission's rules and forms, and that information required to be disclosed by the registrant has been accumulated and communicated to the registrant's management, including its principal executive officer and principal financial officer, or persons performing similar functions as appropriate to allow timely decisions regarding required disclosure.
|
|
(b)
|
Fair Value Accounting—Accounting standards require certain assets and liabilities be reported at fair value in the financial statements and provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the inputs and valuation techniques used to measure fair value.
|
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made know to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and
|
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
|
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date: April 7, 2011
|
/s/ Luke E. Sims
|
|
Luke E. Sims
|
|
President and Chief Executive Officer
|
|
(Principal Executive Officer)
|
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made know to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and
|
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
|
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date: April 7, 2011
|
/s/ David C. Sims
|
|
David C. Sims
|
|
Chief Financial Officer
|
|
(Principal Financial Officer)
|